Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      Manipal Health appoints Dilip Jose as MD and CEO

      Manipal Health appoints Dilip Jose as MD and CEO

      Ruby Khatun Khatun10 Nov 2017 10:07 AM IST
      New Delhi: Manipal Health Enterprises announced the appointment of Dilip Jose as the Managing Director and CEO of the company.He will take charge from...
      GSK appoints scientist Barron as new Research and Development head

      GSK appoints scientist Barron as new Research and Development head

      Ruby Khatun Khatun10 Nov 2017 9:47 AM IST
      LONDON: GlaxoSmithKline (GSK) has poached veteran drug industry scientist Hal Barron from Alphabet-funded Calico to be its research head as new Chief...
      Thousands of drugs at risk if no Brexit deal, companies warn

      Thousands of drugs at risk if no Brexit deal, companies warn

      Ruby Khatun Khatun10 Nov 2017 9:30 AM IST
      Supplies of thousands of medicines are at risk of disruption if Britain leaves the European Union without a trade deal, European pharmaceutical...
      MORE DRUGS added to the Schedule H list

      MORE DRUGS added to the Schedule H list

      Ruby Khatun Khatun9 Nov 2017 11:38 AM IST
      Through a recent gazette notification, Ministry of Health And Family Welfare has extended the list of schedule H drugs by adding more drugs to...
      Mylan seeks EMA approval for 2 biosimilars

      Mylan seeks EMA approval for 2 biosimilars

      Ruby Khatun Khatun9 Nov 2017 10:32 AM IST
      New Delhi: Biocon said that its partner Mylan has re-submitted marketing authorization applications with the European Medicines Agency for two...
      Alembic Pharma Q2 net rises over 1 percent to Rs 121 crore

      Alembic Pharma Q2 net rises over 1 percent to Rs 121 crore

      Ruby Khatun Khatun9 Nov 2017 10:16 AM IST
      New Delhi: Alembic Pharmaceuticals reported a 1.44 percent increase in consolidated net profit at Rs 121.56 crore for the second quarter ended...
      FDA clears common blood cell count test that offers faster results for patients and providers

      FDA clears common blood cell count test that offers faster results for patients and providers

      Ruby Khatun Khatun9 Nov 2017 9:49 AM IST
      The U.S. Food and Drug Administration (FDA) cleared a complete blood cell count (CBC) test that, based on its categorization, can be run in more...
      Ayurveda firm Kapiva to raise 8 million dollars

      Ayurveda firm Kapiva to raise 8 million dollars

      Ruby Khatun Khatun9 Nov 2017 9:37 AM IST
      A healthcare startup Kapiva Ayurveda is planning to raise about $8 million within a year-and-half to expand its product portfolio and invest in...
      Mallinckrodt dives as sales of main drug Acthar disappoint

      Mallinckrodt dives as sales of main drug Acthar disappoint

      Ruby Khatun Khatun9 Nov 2017 9:37 AM IST
      Shares of Mallinckrodt Plc plunged more than 30 percent to an all-time low on Tuesday after the drugmaker reported disappointing quarterly revenue and...
      US senators press Allergan for details on patent deal with tribe

      US senators press Allergan for details on patent deal with tribe

      Ruby Khatun Khatun9 Nov 2017 9:15 AM IST
      A group of U.S. senators on Tuesday asked drugmaker Allergan Plc to produce documents relating to its agreement to transfer patents to a Native...
      Cipla shares tank over 7 percent, mcap falls by Rs 3,785.5 crore

      Cipla shares tank over 7 percent, mcap falls by Rs 3,785.5 crore

      Ruby Khatun Khatun8 Nov 2017 10:21 AM IST
      New Delhi: Shares of Cipla slumped over 7 percent even as the company reported a consolidated net profit of Rs 434.95 crore for the second quarter...
      Lupin gets warning letter from USFDA for Goa, Indore units

      Lupin gets warning letter from USFDA for Goa, Indore units

      Ruby Khatun Khatun8 Nov 2017 10:10 AM IST
      New Delhi: Drug firm Lupin said it has received a warning letter from the US health regulator for its manufacturing facilities in Goa and Pithampur,...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok